TLDR: CustoMED, a pioneer in AI-driven orthopedic solutions, has successfully closed a $6 million seed funding round. This investment will enable the company to scale its cloud-based platform, which leverages artificial intelligence and 3D printing to create patient-specific surgical tools and implants, aiming to enhance precision and efficiency in orthopedic procedures globally.
RAMAT GAN, Israel – CustoMED, an innovative company at the forefront of AI-driven, surgeon-first platforms for patient-specific orthopedic solutions, announced today the successful completion of its seed funding round, raising a total of $6 million. The funding round saw participation from notable investors including Longevity Venture Partners, Varana Capital, Flag Capital, the Israel Innovation Authority, a prominent orthopedic implant company, and Avishai Abrahami, Co-founder and CEO of Wix. This significant capital infusion is set to accelerate CustoMED’s expansion into additional automated orthopedic indications, support crucial US and EU regulatory milestones with approvals anticipated for 2026, and facilitate the global deployment of its on-demand manufacturing model.
CustoMED’s groundbreaking cloud-based platform integrates artificial intelligence and automation with advanced 3D printing technology. This allows for the rapid generation of patient-specific surgical tools and implants directly from a surgeon’s pre-operative plan, reducing the time from weeks to mere minutes. These personalized devices can be produced either onsite or through certified partners, seamlessly integrating into existing surgical workflows. This approach is designed to minimize intraoperative errors, lead to more predictable outcomes, and empower surgeons with full creative and clinical control over their procedures.
The technology has already demonstrated its efficacy in hundreds of successful surgeries worldwide, with thousands more procedures slated for the upcoming year. Or Benifla, Co-founder of CustoMED, emphasized the company’s mission, stating, “CustoMED’s patient-specific surgical tools enable more precise orthopedic surgeries through affordable, real-time solutions delivered directly into the operating room. By putting scalable, personalized technology directly in surgeons’ hands, our mission is to make computer-guided surgery fast, accessible, and routine, transforming what was once a boutique process into standard of care for every patient.”
CustoMED was co-founded by Dr. Amit Zabatani, Or Benifla, and Alon Jacobi. The company originated from the Sheba Medical Center’s 3D Printing & Innovation Lab, established in 2018 by Dr. Dina Orkin alongside the CustoMED co-founders. Prof. Eyal Zimlichman, Founder and Director of ARC Innovation and Chief Innovation, Transformation, and AI Officer at Sheba Medical Center, highlighted the company’s impact: “CustoMED is embedding precision and surgeon-directed tools into everyday workflows, shortening the path from imaging to the operating room while preserving governance, quality, and safety. The company exemplifies ARC’s mission to translate clinical insight into scalable, real-world impact.”
Also Read:
- Wild Moose Secures $7M Seed Funding to Revolutionize Incident Response with AI-Powered SRE Platform
- Mark Cuban’s Cost Plus Drugs Partners with Medchat.ai to Integrate AI for Enhanced Customer Support and Affordability
This funding round marks a pivotal step for CustoMED as it continues to revolutionize orthopedic surgery by making personalized, AI-powered 3D printed solutions a standard of care.
